Efficacy of anti-Aβ antibody isotypes used for intracerebroventricular immunization in TgCRND8

Neuroscience Letters

Volumn 375, Issue 3, 2005, Pages 143-147

  Chauhan, Neelima B ^a,b,c   Siegel, George J ^c,d  

^a JESSE BROWN VA MEDICAL CENTER   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

Alzheimer's disease; Amyloid; Cerebral hemorrhage; EFRH; IgG1; IgG2a; IgG2b

Indexed keywords

AMYLOID BETA ANTIBODY; AMYLOID BETA PROTEIN; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G2B; INTERLEUKIN 1BETA; PROTEIN ANTIBODY; UNCLASSIFIED DRUG; ALZHEIMER DISEASE VACCINE; AMYLOID PRECURSOR PROTEIN; ANTIIDIOTYPIC ANTIBODY; IMMUNOGLOBULIN CLASS; LIPOPOLYSACCHARIDE;

ALZHEIMER DISEASE; AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; BLEEDING; BRAIN; BRAIN TISSUE; CONTROLLED STUDY; DRUG EFFICACY; HISTOLOGY; IMMUNIZATION; IN VITRO STUDY; IN VIVO STUDY; KIDNEY; LIVER; LIVER TOXICITY; MOUSE; NEPHROTOXICITY; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DENSITOMETRY; DISEASE MODEL; GENETICS; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; INFLAMMATION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; METABOLISM; METHODOLOGY; PATHOLOGY; SENILE PLAQUE; SPLEEN; STAINING; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; ALZHEIMER VACCINES; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; ANTIBODIES, ANTI-IDIOTYPIC; BRAIN; DENSITOMETRY; DISEASE MODELS, ANIMAL; IMMUNOGLOBULIN ISOTYPES; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INJECTIONS, INTRAVENTRICULAR; KIDNEY; LIPOPOLYSACCHARIDES; LIVER; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; SENILE PLAQUES; SPLEEN; STAINING AND LABELING;

EID: 13444283725     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2004.10.090     Document Type: Article

References (24)

1. R. Andre, R.D. Wheeler, P.D. Collins, G.N. Luheshi, S. Pickering-Brown, I. Kimber, N.J. Rothwell, and E. Pinteaux Identification of a truncated IL-18R beta mRNA: a putative regulator of IL-18 expressed in rat brain J. Neuroimmunol. 145 1-2 2003 40 45
2. C.S. Atwood, G. Perry, and M.A. Smith Cerebral hemorrhage and amyloid-beta Science 299 5609 2003 1014
3. N.B. Chauhan, and G.J. Siegel Reversal of amyloid beta toxicity in Alzheimer's disease model Tg2576 by intraventricular antiamyloid beta antibody J. Neurosci. Res. 69 1 2002 10 23
4. N.B. Chauhan, and G.J. Siegel Intracerebroventricular passive immunization with anti-Abeta antibody in Tg2576 J. Neurosci. Res. 74 1 2003 142 147
5. N.B. Chauhan, G.J. Siegel, and T. Lichtor Distribution of intraventricularly administered antiamyloid-beta peptide (Abeta) antibody in the mouse brain J. Neurosci. Res. 66 2 2001 231 235
6. N.B. Chauhan, G.J. Siegel, T. Lichtor, Effect of age on the duration and extent of amyloid plaque reduction and microglial activation after injection of anti-Abeta antibody into the third ventricle of TgCRND8 mice, J. Neurosci. Res. (2004), in press.
7. E.V. Colapinto, M.R. Zalutsky, G.E. Archer, M.A. Noska, H.S. Friedman, S. Carrel, and D.D. Bigner Radioimmunotherapy of intracerebral human glioma xenografts with 131I-labeled F(ab')2 fragments of monoclonal antibody Mel-14 Cancer Res. 50 6 1990 1822 1827
8. R.B. DeMattos, K.R. Bales, and D.J. Cummins Peripheral anti-A beta antibody alters CNS and plasma A-beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease Proc. Natl. Acad. Sci. U.S.A. 98 15 2001 8850 8855
9. C. Janus, J. Pearson, and J. McLaurin A beta peptide immunization reduces behavioral impairment and plaques in a model of Alzheimer's disease Nature 408 6815 2000 979 982
10. T.L. Kemper Neuroanatomical and neuropathological changes during aging and dementia. M.L. Albert J.E. Knoefel Clinical Neurology of Aging second ed. 1994 Oxford University Press New York 3 67
11. W.L. Klein, G.A. Krafft, and C.E. Finch Targeting small Abeta oligomers: the solution to an Alzheimer's disease conundrum Trends Neurosci. 24 4 2001 219 224
12. M. Liebert, R.L. Wahl, G. Lawless, P.E. McKeever, J.A. Taren, W.H. Beierwaltes, and R. Brasswell Direct stereotactic intracerebral injection of monoclonal antibodies and their fragments: a potential approach to brain tumor immunotherapy Am. J. Physiol. Imaging 5 2 1990 55 59
13. A. Monsonego, V. Zota, and A. Karni Increased T cell reactivity to amyloid beta protein in older humans and patients with Alzheimer disease J. Clin. Invest. 11 3 2003 415 422
14. D. Morgan, D.M. Diamond, and P.E. Gottschall A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease Nature 408 6815 2000 982 985 erratum in: Nature 412 (6847) (2001, August 9) 660
15. J.A. Nicoll, D. Wilkinson, C. Holmes, P. Steart, H. Markham, and R.O. Weller Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report Nat. Med. 9 4 2003 448 452
16. M. Pfeifer, S. Boncristiano, L. Bondolfi, A. Stalder, T. Deller, M. Staufenbiel, P.M. Mathews, and M. Jucker Cerebral hemorrhage after passive anti-Abeta immunotherapy Science 298 5597 2002 1379
17. D. Schenk, R. Barbour, W. Dunn, G. Gordon, H. Grajeda, T. Guido, K. Hu, J. Huang, K. Johnson-Wood, K. Khan, D. Kholodenko, M. Lee, Z. Liao, I. Lieberburg, R. Motter, L. Mutter, F. Soriano, G. Shopp, N. Vasquez, C. Vandevert, S. Walker, M. Wogulis, T. Yednock, D. Games, and P. Seubert Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse Nature 400 6740 1999 173 177
18. E.M. Sigurdsson, H. Scholtzova, P.D. Mehta, B. Frangione, and T. Wisniewski Immunization with a nontoxic/nonfibrillar amyloid-beta homologous peptide reduces Alzheimer's disease-associated pathology in transgenic mice Am. J. Pathol. 159 2 2001 439 447
19. E.M. Sigurdsson, T. Wisniewski, and B. Frangione A safer vaccine for Alzheimer's disease Neurobiol. Aging 23 6 2002 1001 1008
20. B. Solomon Immunotherapeutic strategies for prevention and treatment of Alzheimer's disease DNA Cell Biol. 20 11 2001 697 703
21. B. Solomon Immunological approaches as therapy for Alzheimer's disease Expert Opin. Biol. Ther. 2 8 2002 907 917
22. T. Town, M. Vendrame, A. Patel, D. Poetter, A. DelleDonne, T. Mori, R. Smeed, F. Crawford, T. Klein, J. Tan, and M. Mullan Reduced Th1 and enhanced Th2 immunity after immunization with Alzheimer's beta-amyloid (1-42) J. Neuroimmunol. 132 1-2 2002 49 59
23. H.L. Weiner, and D.J. Selkoe Inflammation and therapeutic vaccination in CNS diseases Nature 420 6917 2002 879 884
24. D.M. Wilcock, G. DiCarlo, D. Henderson, J. Jackson, K. Clarke, K.E. Ugen, M.N. Gordon, and D. Morgan Intracranially administered anti-Abeta antibodies reduce beta-amyloid deposition by mechanisms both independent of and associated with microglial activation J. Neurosci. 23 9 2003 3745 3751